SCHEMBL31380068

SCHEMBL31380068

Cn1cnnc1C1CCN(C(=O)OC(C)(C)C)C2(CC2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.37
▸ JAK3 P52333 4/20 0.37
▸ JAK2 O60674 4/20 0.37
▸ JAK1 P23458 4/20 0.37
▸ TYK2 P29597 2/20 0.37
▸ HSD11B1 P28845 2/20 0.35
▸ THRB P10828 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ GRIN2B Q13224 1/20 0.34
▸ GRIN2C Q14957 1/20 0.34
▸ PIK3CD O00329 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ GPR119 Q8TDV5 2/20 0.32
▸ QPCT Q16769 1/20 0.32
▸ QPCTL Q9NXS2 1/20 0.32
▸ KDM1A O60341 1/20 0.32
▸ HPGDS O60760 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31320093 0.91 JAK3 (0.34) EPHX2JAK3JAK2JAK1TYK2
SCHEMBL31320087 0.90 JAK3 (0.34) EPHX2JAK3JAK2JAK1TYK2
SCHEMBL22712403 0.80 THRB (0.50) EPHX2JAK3JAK2JAK1TYK2
SCHEMBL24826722 0.74 KDM4E (0.41) EPHX2JAK3JAK2JAK1TYK2
SCHEMBL18788539 0.74 THRB (0.45) EPHX2JAK3JAK2JAK1TYK2
SCHEMBL27167765 0.74 NAMPT (0.40) JAK3JAK1HSD11B1THRBKDM4E
SCHEMBL31320106 0.72 EPHX2 (0.39) EPHX2JAK3JAK2JAK1TYK2
SCHEMBL31380056 0.72 EPHX2 (0.39) EPHX2JAK3JAK2JAK1TYK2
SCHEMBL31320104 0.72 EPHX2 (0.39) EPHX2JAK3JAK2JAK1TYK2
SCHEMBL30683434 0.72 THRB (0.47) EPHX2JAK3JAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066329-A1 PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066329-A1 PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN QPCT, QPCTL, GLUL EPHX2 4746/4885JAK3 2341/4885JAK2 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback